UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

Journal of clinical epidemiology, 2013-02, Vol.66 (2), p.140-150

2013

Link zum Volltext

Verfügbarkeit prüfen

Randomisation to protect against selection bias in healthcare trials

Cochrane database of systematic reviews, 2011-04 (4), p.MR000012

2011

Link zum Volltext

Verfügbarkeit prüfen

Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results

Implementation science : IS, 2013-01, Vol.8 (1), p.6-6, Article 6

2013

Link zum Volltext

Verfügbarkeit prüfen

GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONS

International journal of technology assessment in health care, 2017-01, Vol.33 (2), p.176-182

2017

Link zum Volltext

Verfügbarkeit prüfen

Economic evidence in decision-making process in laboratory medicine

Clinical chemistry and laboratory medicine, 2011-04, Vol.49 (4), p.617-621

2011

Link zum Volltext

Verfügbarkeit prüfen

Dystroglycan Mediates Clustering of Essential GABAergic Components in Cerebellar Purkinje Cells

Frontiers in molecular neuroscience, 2020-08, Vol.13 (9), p.164-164

2020

Link zum Volltext

Verfügbarkeit prüfen

Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation

BMC neuroscience, 2011-10, Vol.12 (1), p.103-103, Article 103

2011

Link zum Volltext

Verfügbarkeit prüfen

Hospital discharge planning and continuity of care for aged people in an Italian local health unit: does the care-home model reduce hospital readmission and mortality rates?

BMC health services research, 2009-02, Vol.9 (1), p.22-22, Article 22

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison between 2-Deoxy-2-[18f]Fluoro-D-Glucose Positron Emission (FDG-PET) and Computed Tomography (CT) for Staging of Patients with Hodgkin's Lymphoma (HL)

Blood, 2005-11, Vol.106 (11), p.975-975

2005

Link zum Volltext

Verfügbarkeit prüfen

Combined differentiating therapy for myelodysplastic syndromes: A phase II study

Leukemia research, 1996-10, Vol.20 (10), p.867-876

1996

Link zum Volltext

Verfügbarkeit prüfen

Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes

Leukemia, 1994-02, Vol.8 (2), p.250-257

1994

Link zum Volltext

Verfügbarkeit prüfen

Establishment from an adult leukemic patient of two novel precursor B cell lines with different growth modality

Leukemia research, 1990, Vol.14 (2), p.177-184

1990

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(11)
Science & Technology
(11)
Humans
(9)
Biological And Medical Sciences
(6)
Medical Sciences
(5)
Decision Making
(4)
Female
(4)
Health Care Sciences & Services
(4)
Aged
(3)
Aged, 80 And Over
(3)
Costs
(3)
Male
(3)
Middle Aged
(3)
Adult
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cell Division
(2)
Communication
(2)
Epidemiology
(2)
Evidence-Based Medicine - Economics
(2)
Evidence-Based Medicine - Standards
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence

Randomisation to protect against selection bias in healthcare trials

Developing and Evaluating Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE): protocol and preliminary results

GRADE EVIDENCE TO DECISION (EtD) FRAMEWORK FOR COVERAGE DECISIONS

Economic evidence in decision-making process in laboratory medicine

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

Dystroglycan Mediates Clustering of Essential GABAergic Components in Cerebellar Purkinje Cells

Treatment-Free Remission in Chronic Myeloid Leukemia Patients Treated With Low-Dose TKIs: A Feasible Option Also in the Real-Life. A Campus CML Study

Neuregulin1/ErbB4-induced migration in ST14A striatal progenitors: calcium-dependent mechanisms and modulation by NMDA receptor activation

Hospital discharge planning and continuity of care for aged people in an Italian local health unit: does the care-home model reduce hospital readmission and mortality rates?

The Combination of Weekly Infusion of Rituximab and Bortezomib Is Effective in Relapsed or Refractory Indolent and Mantle Cell Lymphoma: Long-Term Results of Phase II BRIL06 Study of the Fondazione Italiana Linfomi (FIL)

Imatinib in Very Elderly (> 75 years) CML Patients: Are Low-Doses (<400 mg daily) Enough?

Weekly Infusion of Bortezomib In Combination with Rituximab In Relapsed/Refractory Indolent Non-Follicular and Mantle Cell Lymphoma Is Safe and Effective: Two-Years Analysis of Phase II Trial BRIL06 of Intergruppo Italiano Linfomi (IIL)

IHP Interpretation Criteria of Interim-PET Scan Confirms Prognostic Impact In Early Stage Hodgkin Lymphoma Patients without Bulky Disease

The Outcome of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab-CHOP (R-CHOP) Is Not Predicted by 18-FDG-Positron Emission Tomography/Computerized Tomography (PET) Performed at Intermediate In-Course Evaluation, but Only by PET Assessed at the End of Therapy

The Combination of Bortezomib and Rituximab Is Effective and Safe in Relapsed/Refractory Indolent Non Follicular and Mantle-Cell Non Hodgkin Lymphoma: a Phase II Multicenter Study by Intergruppo Italiano Linfomi

Real-Life Analysis of Dasatinib in Chronic Phase CML Patients Aged > 60 Years Resistant/Intolerant to Imatinib

Comparison between 2-Deoxy-2-[18f]Fluoro-D-Glucose Positron Emission (FDG-PET) and Computed Tomography (CT) for Staging of Patients with Hodgkin's Lymphoma (HL)

Combined differentiating therapy for myelodysplastic syndromes: A phase II study

Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes

Establishment from an adult leukemic patient of two novel precursor B cell lines with different growth modality

Suchergebnisse filtern